跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 63,932 条关于
“lower-risk myelodysplastic syndromes”
全部
63,932
临床试验
49,666
药物
293
机构
45
资讯
13,928
去年
ESA Treatment Shows Survival Benefit in Lower-Risk Myelodysplastic Syndromes
去年
Canakinumab Shows Promise in Treating Relapsed/Refractory Lower-Risk Myelodysplastic Syndromes
2年前
Halia Therapeutics Initiates Phase 2a Trial of First-in-Class NLRP3 Inhibitor HT-6184 for Lower-Risk Myelodysplastic Syndromes
去年
CHMP Recommends Approval of Geron's Rytelo for Lower-Risk Myelodysplastic Syndromes
去年
Luspatercept Demonstrates Sustained Transfusion Independence in Myelodysplastic Syndromes
去年
Luspatercept Demonstrates Significant Reduction in Transfusion Burden in Lower-Risk MDS Patients: COMMANDS Trial
2年前
FDA Approves RYTELO™ (imetelstat) for Lower-Risk MDS with Transfusion-Dependent Anemia
去年
Ryvu Therapeutics Doses First Patient in Phase II REMARK Trial of RVU120 for Lower-Risk MDS
去年
MAXILUS Trial Investigates Higher Luspatercept Dose in Lower-Risk MDS
11天前
King's College Hospital recruits world's first patient in Phase 3 trial of erlitercept for lower-risk MDS
第 1 页，共 1393 页
上一页
下一页
